Literature DB >> 8182155

Prostacyclin synthesis in ovine pulmonary artery is developmentally regulated by changes in cyclooxygenase-1 gene expression.

T S Brannon1, A J North, L B Wells, P W Shaul.   

Abstract

Prostacyclin (PGI2) is a key mediator of pulmonary vasomotor tone during late gestation and in the newborn, and its production in whole lung increases during that period. We investigated the developmental regulation of PGI2 synthesis in ovine intrapulmonary artery (PA) segments from 110 to 115 d (F1) and 125 to 135 d gestation fetal lambs (F2, term = 144 d) and 1- and 4-wk-old newborn lambs (NB1 and NB2). Basal PGI2 rose fourfold from F1 to F2, fourfold from F2 to NB1, and twofold from NB1 to NB2. In all age groups 66-72% of PGI2 was derived from the endothelium. Similar fold increases in PGI2 were observed with maturation in intact and endothelium-denuded segments. In intact PA from F2, NB1, and NB2, basal PGI2 synthesis and synthesis maximally stimulated by bradykinin, A23187, or arachidonic acid rose with development in a comparable manner. In contrast, PGI2 synthesis stimulated by exogenous PGH2, the product of cyclooxygenase, was similar at all ages. Immunoblot analyses of PA from F2, NB1, and NB2 revealed that there is a sixfold maturational increase in cyclooxygenase-1 protein; the cyclooxygenase-2 isoform was not detectable. Cyclooxygenase-1 mRNA abundance in whole lung also rose with development. Thus, PGI2 synthesis in ovine PA endothelium and vascular smooth muscle increases markedly during late fetal and early newborn life; the increase is due to a rise in cyclooxygenase activity related to enhanced expression of cyclooxygenase-1. We conclude that there is developmental regulation of PA cyclooxygenase-1 gene expression, and that this may be critical to successful cardiopulmonary transition and function in the newborn.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8182155      PMCID: PMC294372          DOI: 10.1172/JCI117220

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.

Authors:  M K O'Banion; V D Winn; D A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Acute effects of partial compression of ductus arteriosus on fetal pulmonary circulation.

Authors:  S H Abman; F J Accurso
Journal:  Am J Physiol       Date:  1989-08

4.  Angiotensin II prevents hypoxic pulmonary hypertension and vascular changes in rat.

Authors:  M Rabinovitch; M Mullen; H C Rosenberg; K Maruyama; H O'Brodovich; P M Olley
Journal:  Am J Physiol       Date:  1988-03

5.  Oxygen-related prostaglandin synthesis in ductus arteriosus and other vascular cells.

Authors:  M Rabinovitch; N Boudreau; G Vella; F Coceani; P M Olley
Journal:  Pediatr Res       Date:  1989-10       Impact factor: 3.756

6.  The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.

Authors:  J Y Fu; J L Masferrer; K Seibert; A Raz; P Needleman
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

7.  Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension.

Authors:  D B Badesch; E C Orton; L M Zapp; J Y Westcott; J Hester; N F Voelkel; K R Stenmark
Journal:  Am J Respir Cell Mol Biol       Date:  1989-12       Impact factor: 6.914

8.  Human cyclooxygenase-2 cDNA.

Authors:  T Hla; K Neilson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Changes in lung eicosanoid content during normal and abnormal transition in perinatal lambs.

Authors:  S H Abman; K R Stenmark
Journal:  Am J Physiol       Date:  1992-02

10.  Oxygen modulates endothelium-derived relaxing factor production in fetal pulmonary arteries.

Authors:  P W Shaul; M A Farrar; T M Zellers
Journal:  Am J Physiol       Date:  1992-02
View more
  17 in total

1.  Function of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the ductus arteriosus from foetal lamb: differential development and change by oxygen and endotoxin.

Authors:  F Coceani; C Ackerley; E Seidlitz; L Kelsey
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 2.  Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.

Authors:  Nicolas F M Porta; Robin H Steinhorn
Journal:  Clin Perinatol       Date:  2012-03       Impact factor: 3.430

Review 3.  Neonatal pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Crit Care Med       Date:  2010-03       Impact factor: 3.624

Review 4.  Controversies in the identification and management of acute pulmonary hypertension in preterm neonates.

Authors:  Regan E Giesinger; Kiran More; Jodie Odame; Amish Jain; Robert P Jankov; Patrick J McNamara
Journal:  Pediatr Res       Date:  2017-10-04       Impact factor: 3.756

5.  Characterization of a novel transcript of prostaglandin endoperoxide H synthase 1 with a tissue-specific profile of expression.

Authors:  M H Plant; O Laneuville
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

Review 6.  Pharmacotherapy for pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

7.  COX-1 vs. COX-2 as a determinant of basal tone in the internal anal sphincter.

Authors:  Márcio A F de Godoy; Neeru Rattan; Satish Rattan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-04       Impact factor: 4.052

8.  Persistent inactivation of macrophage cyclooxygenase-2 in mycobacterial pulmonary inflammation.

Authors:  Tsutomu Shinohara; Traci Pantuso; Shizuka Shinohara; Mari Kogiso; Quentin N Myrvik; Ruth Ann Henriksen; Yoshimi Shibata
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

9.  Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone.

Authors:  Xavier Norel; Laurence Walch; Jean-Pierre Gascard; Vincent deMontpreville; Charles Brink
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

10.  Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium.

Authors:  S S Jun; Z Chen; M C Pace; P W Shaul
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.